NetworkNewsBreaks – Avricore Health Inc. (TSX.V:
Post# of 61
(Total Views: 262)
Posted On: 08/19/2021 4:04:34 PM
NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Positioning in Growing Point-of-Care Diagnostics and Testing Market
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) completed the initial systems testing on HealthTab(TM), its turnkey point-of-care testing solution for pharmacies, demonstrating that it was operating successfully after implementation in the first 11 Shoppers Drug Mart(R) locations where it was launched. “The rollout is a part of the master agreement and statement of work. Under this agreement, the initial Ontario locations receive the point-of-care testing platform from HealthTab(TM) that features the Afinion2(TM) blood chemistry analyzers by Abbott Rapid Diagnostics,” reads a recent article. “The program’s initial focus is to screen patients at risk or already diagnosed with diabetes and cardiovascular disease, offering a better way to manage the conditions for a higher quality life. As key milestones are accomplished, the company will add more locations to the HealthTab(TM) network, further expanding per the agreement with Shoppers Drug Mart Canada. . . . a successful rollout of the HealthTab(TM) platform will help position Avricore Health as a leading company in the point-of-care diagnostics and testing market, which is expected to gain momentum in the coming years.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) completed the initial systems testing on HealthTab(TM), its turnkey point-of-care testing solution for pharmacies, demonstrating that it was operating successfully after implementation in the first 11 Shoppers Drug Mart(R) locations where it was launched. “The rollout is a part of the master agreement and statement of work. Under this agreement, the initial Ontario locations receive the point-of-care testing platform from HealthTab(TM) that features the Afinion2(TM) blood chemistry analyzers by Abbott Rapid Diagnostics,” reads a recent article. “The program’s initial focus is to screen patients at risk or already diagnosed with diabetes and cardiovascular disease, offering a better way to manage the conditions for a higher quality life. As key milestones are accomplished, the company will add more locations to the HealthTab(TM) network, further expanding per the agreement with Shoppers Drug Mart Canada. . . . a successful rollout of the HealthTab(TM) platform will help position Avricore Health as a leading company in the point-of-care diagnostics and testing market, which is expected to gain momentum in the coming years.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Avricore Health Inc. (AVCRF) Stock Research Links
Scroll down for more posts ▼